Sai Life Sciences Limited has informed the Exchange regarding a press release dated April 03, 2025, titled "Sai Life Sciences sets up Peptide Research Center in India".
SAILIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sai Life Sciences Limited has informed the stock exchange about a press release dated April 3, 2025, announcing the establishment of a Peptide Research Center in India. The company, which operates in the pharmaceutical contract research and development space, is expanding into peptide-based research capabilities. Peptide therapeutics is a fast-growing segment in the global pharma industry. Specific details such as location, investment size, or expected employment numbers were not disclosed in the filing summary.
This is a strategic R&D expansion that strengthens the company's presence in the high-growth peptide therapeutics segment, potentially supporting long-term business growth and new client wins.